REMOVED: Plasma Steroids and Endocannabinoids Used as Biomarkers to Assess the Pruritus Severity of Patients With Prurigo Nodularis L. Chu, L.-K. Wang, Y. Wu, H. Yang, W. Wang, Q. Lu, H. Deng

Nemolizumab: An Innovative Biologic Treatment to Control Interleukin 31, a Key Mediator in Atopic Dermatitis and Prurigo Nodularis E. Serra-Baldrich, L.F. Santamaria-Babí, J. Francisco Silvestre

Prurigiform Angiomatosis: A New Term for Describing the Prominent Dermal Angiomatoid Proliferation Underlying Epidermal Changes in Prurigo Nodularis/Lichen Simplex Chronicus R. Albero-González, D. Rizo-Potau, L. Alós Hernández, P. Castillo Fernández, A. García-Herrera